6-yr court battle over hepatitis C completed

6-yr court battle over hepatitis C completed

TOKYO, Japan - Michiko Yamaguchi, representative of the plaintiffs group, signs an agreement with Nihon Pharmaceutical Co. at the drug firm's headquarters in Tokyo's Chiyoda Ward on Dec. 14 to end a series of damages suits over tainted blood products that infected the patients with a hepatitis virus.

  • Product Code
  • ILEA001131040
  • Registered date
  • 2008/12/14 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2008 Kyodo News
  • Media size
  • 1303 × 1581 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 300.48(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Plaintiffs of Iressa cancer drug case

    Plaintiffs of Iressa cancer drug case

    TOKYO, Japan - Three deceased patients' relatives who sued the Japanese government and the Japanese unit of British pharmaceutical company AstraZeneca PLC, demanding compensation for the side effects caused by the lung cancer drug Iressa, walk to the Tokyo High Court on Nov. 15, 2011. The high court on the same day ruled the government and AstraZeneca K.K. are not responsible for damages, overturning a lower court ruling. The plaintiffs sought a combined 77 million yen in compensation.
      Lower house passes hepatitis bill, enactment seen certain

      Lower house passes hepatitis bill, enactment seen certain

      TOKYO, Japan - Michiko Yamaguchi, the representative of a national group of hepatitis patients who have filed a lawsuit against the government and drug makers, speaks at a news conference in Tokyo on Nov. 26 after a plenary session of the House of Representatives passed a measure to support hepatitis patients.
        6-yr court battle over hepatitis C completed

        6-yr court battle over hepatitis C completed

        TOKYO, Japan - Tsutomu Miura (R), president of Nihon Pharmaceutical Co., bows in apology to a group of hepatitis patients, including plaintiffs' group representative Michiko Yamaguchi (L), at the drug firm's headquarters in Tokyo's Chiyoda Ward on Dec. 14 after they signed an agreement to end a series of damages suits over tainted blood products that infected the patients with a hepatitis virus.
          6-yr court battle over hepatitis C completed

          6-yr court battle over hepatitis C completed

          TOKYO, Japan - Tsutomu Miura, president of Nihon Pharmaceutical Co., signs an agreement with a group of hepatitis patients at the firm's headquarters in Tokyo's Chiyoda Ward on Dec. 14 to end a series of damages suits over the drug firm's tainted blood products that infected the patients with a hepatitis virus.
            First settlement reached in hepatitis damages suits against state

            First settlement reached in hepatitis damages suits against state

            FUKUOKA, Japan - A total of 29 hepatitis C sufferers suing the state and drugmakers for damages settled suits with the state in Osaka and Fukuoka on Feb. 4, the first such settlement among a series of similar lawsuits filed by about 240 people nationwide since 2002. Photo shows plaintiffs smiling during a news conference the same day after the settlement of their suit at the Fukuoka High Court.